Epkinri subcutaneous injection 4mg, manufactured by Genmab, contains Epcoritamab (genetical recombination). This bispecific antibody targets CD20 on B-cells and CD3 on T-cells, bringing them into close proximity to induce T-cell-mediated killing of malignant B-cells. It is supplied as 4mg in 0.8mL per bottle, with YJ code 4291469A1028.
Epkinri subcutaneous injection 4mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →